303 related articles for article (PubMed ID: 8097538)
1. Centrally acting serotonergic and dopaminergic agents. 2. Synthesis and structure-activity relationships of 2,3,3a,4,9,9a-hexahydro-1H-benz[f]indole derivatives.
Lin CH; Haadsma-Svensson SR; Phillips G; Lahti RA; McCall RB; Piercey MF; Schreur PJ; Von Voigtlander PF; Smith MW; Chidester CG
J Med Chem; 1993 Apr; 36(8):1069-83. PubMed ID: 8097538
[TBL] [Abstract][Full Text] [Related]
2. Centrally acting serotonergic and dopaminergic agents. 1. Synthesis and structure-activity relationships of 2,3,3a,4,5,9b-hexahydro-1H-benz[e]indole derivatives.
Lin CH; Haadsma-Svensson SR; Lahti RA; McCall RB; Piercey MF; Schreur PJ; Von Voigtlander PF; Smith MW; Chidester CG
J Med Chem; 1993 Apr; 36(8):1053-68. PubMed ID: 8097537
[TBL] [Abstract][Full Text] [Related]
3. Centrally acting serotonergic agents. Synthesis and structure-activity relationships of C-1- or C-3-substituted derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin.
Lin CH; Haadsma-Svensson SR; Lahti RA; McCall RB; Piercey MF; Schreur PJ; VonVoigtlander PF; Chidester CG
J Med Chem; 1993 Mar; 36(6):671-82. PubMed ID: 8459396
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activity of cis-(3aR)-(-)-2,3,3a,4,5,9b-hexahydro- 3-propyl-1H-benz[e]indole-9-carboxamide: a potent and selective 5-HT1A receptor agonist with good oral availability.
Lin CH; Haadsma-Svensson SR; Phillips G; McCall RB; Piercey MF; Smith MW; Svensson K; Carlsson A; Chidester CG; Von Voigtlander PF
J Med Chem; 1993 Jul; 36(15):2208-18. PubMed ID: 8340922
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 5-HT1A and dopamine D2 pharmacophores. X-ray structures and affinities of conformationally constrained ligands.
Chidester CG; Lin CH; Lahti RA; Haadsma-Svensson SR; Smith MW
J Med Chem; 1993 May; 36(10):1301-15. PubMed ID: 8496900
[TBL] [Abstract][Full Text] [Related]
6. C-9 and N-substituted analogs of cis-(3aR)-(-)-2,3,3a,4,5,9b-hexahydro-3- propyl-1H-benz[e]indole-9-carboxamide: 5-HT1A receptor agonists with various degrees of metabolic stability.
Haadsma-Svensson SR; Svensson K; Duncan N; Smith MW; Lin CH
J Med Chem; 1995 Feb; 38(4):725-34. PubMed ID: 7861420
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Pharmacology of the enantiomers of the potential atypical antipsychotic agents 5-OMe-BPAT and 5-OMe-(2,6-di-OMe)-BPAT.
Homan EJ; Copinga S; Unelius L; Jackson DM; Wikström HV; Grol CJ
Bioorg Med Chem; 1999 Jul; 7(7):1263-71. PubMed ID: 10465402
[TBL] [Abstract][Full Text] [Related]
8. (S)- and (R)-8-(di-n-propylamino)-6,7,8,9-tetrahydro-3H-benz[e]indole-1- carbaldehyde: a new class of orally active 5-HT1A-receptor agonists.
Stjernlöf P; Gullme M; Elebring T; Andersson B; Wikström H; Lagerquist S; Svensson K; Ekman A; Carlsson A; Sundell S
J Med Chem; 1993 Jul; 36(15):2059-65. PubMed ID: 8340910
[TBL] [Abstract][Full Text] [Related]
9. trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazines.
Perrone R; Berardi F; Colabufo NA; Leopoldo M; Lacivita E; Tortorella V; Leonardi A; Poggesi E; Testa R
J Med Chem; 2001 Dec; 44(25):4431-42. PubMed ID: 11728188
[TBL] [Abstract][Full Text] [Related]
10. 2-aminotetralin-derived substituted benzamides with mixed dopamine D2, D3, and serotonin 5-HT1A receptor binding properties: a novel class of potential atypical antipsychotic agents.
Homan EJ; Copinga S; Elfström L; van der Veen T; Hallema JP; Mohell N; Unelius L; Johansson R; Wikström HV; Grol CJ
Bioorg Med Chem; 1998 Nov; 6(11):2111-26. PubMed ID: 9881101
[TBL] [Abstract][Full Text] [Related]
11. Orally active central dopamine and serotonin receptor ligands: 5-, 6-, 7-, and 8-[[trifluoromethyl)sulfonyl]oxy]-2-(di-n-propylamino)tetralins and the formation of active metabolites in vivo.
Sonesson C; Boije M; Svensson K; Ekman A; Carlsson A; Romero AG; Martin IJ; Duncan JN; King LJ; Wikström H
J Med Chem; 1993 Oct; 36(22):3409-16. PubMed ID: 8230131
[TBL] [Abstract][Full Text] [Related]
12. Derivatives of cis-2-amino-8-hydroxy-1-methyltetralin: mixed 5-HT1A-receptor agonists and dopamine D2-receptor antagonists.
Liu Y; Yu H; Mohell N; Nordvall G; Lewander T; Hacksell U
J Med Chem; 1995 Jan; 38(1):150-60. PubMed ID: 7530773
[TBL] [Abstract][Full Text] [Related]
13. 6,7,8,9-Tetrahydro-N,N-di-n-propyl-3H-benzindol-8-amines. Derivatives as potent and orally active serotonin 5-HT1A receptor agonists.
Stjernlöf P; Elebring T; Nilsson J; Andersson B; Lagerkvist S; Svensson K; Ekman A; Carlsson A; Wikström H
J Med Chem; 1994 Sep; 37(20):3263-73. PubMed ID: 7932553
[TBL] [Abstract][Full Text] [Related]
14. cis-1,2,3a,4,5,9b-hexahydro-3H-benz[e]indoles: synthesis and in vitro binding affinity at dopamine D1 and D2 receptors.
Cruse SF; Lear J; Klein CL; Andersen PH; Dick RM; Crider AM
J Pharm Sci; 1993 Mar; 82(3):334-9. PubMed ID: 8095545
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel 5-substituted 3-amino-3,4-dihydro-2H-1-benzopyran derivatives and their interactions with the 5-HT1A receptor.
Hammarberg E; Nordvall G; Leideborg R; Nylöf M; Hanson S; Johansson L; Thorberg SO; Tolf BR; Jerning E; Svantesson GT; Mohell N; Ahlgren C; Westlind-Danielsson A; Csöregh I; Johansson R
J Med Chem; 2000 Jul; 43(15):2837-50. PubMed ID: 10956192
[TBL] [Abstract][Full Text] [Related]
16. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.
Collins GT; Witkin JM; Newman AH; Svensson KA; Grundt P; Cao J; Woods JH
J Pharmacol Exp Ther; 2005 Jul; 314(1):310-9. PubMed ID: 15833897
[TBL] [Abstract][Full Text] [Related]
17. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T
Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561
[TBL] [Abstract][Full Text] [Related]
18. Novel 2-substituted tetrahydro-3H-benz[e]indolamines: highly potent and selective agonists acting at the 5-HT1A receptor as possible anxiolytics and antidepressants.
Romero AG; Leiby JA; McCall RB; Piercey MF; Smith MW; Han F
J Med Chem; 1993 Jul; 36(15):2066-74. PubMed ID: 8101876
[TBL] [Abstract][Full Text] [Related]
19. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
[TBL] [Abstract][Full Text] [Related]
20. C5-substituted derivatives of 5-OMe-BPAT: synthesis and interactions with dopamine D2 and serotonin 5-HT1A receptors.
Homan EJ; Tulp MT; Nilsson JE; Wikström HV; Grol CJ
Bioorg Med Chem; 1999 Nov; 7(11):2541-8. PubMed ID: 10632064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
